companydata.dkBioMed Invest ApS: Financial statements 2020
CVR: 29844925
BioMed Invest ApS (CVR 29844925) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 27,606 and a net result of DKK 5,871 compared with DKK 16,645 the year before. Equity amounted to DKK 1,399,557. The solvency ratio was 95.4%.
- Gross Profit
- 27,606 kr.
- Profit/Loss
- 5,871 kr.
- Equity
- 1,399,557 kr.
- Total Assets
- 1,466,483 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 28 t. | 6 t. | 1.4 mio. | - |
| 2019 | - | -16 t. | 17 t. | 1.5 mio. | - |
| 2018 | - | -35 t. | -16 t. | 1.5 mio. | - |
| 2017 | - | 137 t. | -183 t. | 1.6 mio. | - |
| 2016 | - | 77 t. | -771 t. | 1.9 mio. | - |
How creditworthy is BioMed Invest ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
BioMed Invest ApS has published its annual report for 2019. Gross profit came to DKK -16,394, and the net result was DKK 16,645.
About BioMed Invest ApS
BioMed Invest ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2006. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Erling Henningsen. The company is owned by Erling Henningsen. In 2025, the company reported a gross profit of DKK 12,474 and a net result of DKK -80,320 compared with DKK 451,303 the year before. Equity amounted to DKK 8,740,167.